<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01943617</url>
  </required_header>
  <id_info>
    <org_study_id>2013ZX10002004-3</org_study_id>
    <nct_id>NCT01943617</nct_id>
  </id_info>
  <brief_title>Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis</brief_title>
  <official_title>Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Public Health Clinical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sir Run Run Shaw Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing YouAn Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing 302 Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Ditan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huashan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fifth Hospital of Shijiazhuang City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Logistics University of Chinese People's Armed Police Forces</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Shanxi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital of Yanbian University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Friendship Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Six hundreds patients with chronic hepatitis B clinically diagnosed as compensated liver
      cirrhosis are randomly assigned in a 1:1 ratio. One arm is entecavir alone for 2 years; the
      other is entecavir alone for the first 0.5 year, entecavir plus thymosin-α for 1 year,
      entecavir for another additional 0.5 year.Patients will be assessed at baseline, at every six
      months for blood cell count, liver function test, HBVDNA, AFP, prothrombin time, liver
      ultrasonography, and Fibroscan;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decompensated rate of Liver Cirrhosis after 2 years treatment</measure>
    <time_frame>2 years</time_frame>
    <description>Decompensated rate of Liver Cirrhosis (ascites, hepatic encephalopathy, esophageal varices bleeding and Hepatocellular Carcinoma) after 2 years treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Child-Pugh and MELD scores</measure>
    <time_frame>1 and 2-year</time_frame>
    <description>The progress of Child-Pugh and MELD scores after 1 and 2-year treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The HBV DNA undetectable rate</measure>
    <time_frame>1 and 2-year</time_frame>
    <description>The HBV DNA undetectable rate after 1 and 2-year treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver stiffness measurement</measure>
    <time_frame>1 and 2-year</time_frame>
    <description>Liver stiffness measurement change after 1 and 2-year treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>1 and 2-year</time_frame>
    <description>Quality of life after 1 and 2-year treatment by SF-36 and EQ-5D questionares</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Entecavir Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Entecavir, 0.5mg, qd, oral, for 2 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Entecavir plus thymosin therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Entecavir plus thymosin-α 1.6μg, Twice a week, ih, in the middle one year</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Entecavir</intervention_name>
    <description>anti-viral therapy</description>
    <arm_group_label>Entecavir Therapy</arm_group_label>
    <arm_group_label>Entecavir plus thymosin therapy</arm_group_label>
    <other_name>Entecavir dispersible tablets</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thymosin-α</intervention_name>
    <description>anti-viral and antitherapy</description>
    <arm_group_label>Entecavir plus thymosin therapy</arm_group_label>
    <other_name>Zadaxin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients from age 18 to 65 years ;

          2. Male or female;

          3. Treatment-naive patients of clinically diagnosed as HBV-induced compensated
             cirrhosis(meet one of the following two criterions);

               1. endoscopy: esophageal varices , exclusion of noncirrhotic portal hypertension

               2. if no endoscopy,should meet two of the four Criterias:

                    -  Imaging (US, CT or MRI, et al) showing Surface nodularity: Echogenecity

                    -  Platelet (PLT) &lt; 100×10 &lt; 9 &gt;/L , no other interpretation

                    -  Albumin (ALB) &lt; 35.0 g/L, or International Standard Value (INR) &gt; 1.3
                       (Prothrombin Time (PT) prolonged &gt; 3s), or Cholinesterase (CHE) decrease

                    -  Liver stiffness measurement value &gt; 12.4 kpa (ALT&lt;5×ULN)

          4. HBeAg-positive, HBVDNA &gt; 2×10&lt;3&gt; IU/ml or with HBeAg-negative patients, HBVDNA &gt;
             2×10&lt;2&gt; IU/ml;

          5. Agree to be followed up regularly;

          6. Signature of written inform consent.

        Exclusion Criteria:

          1. Patients with decompensated cirrhosis: including ascites, hepatic encephalopathy,
             esophageal varices bleeding or other complications of decompensated cirrhosis or
             hepatocelluar carcinoma;

          2. Patients who are allergic to entecavir, thymosin or their components, and those
             considered not suitable for medicine in this study;

          3. Patients with HCV or HIV infection, alcoholic liver disease, autoimmune liver disease,
             genetic liver disease, drug-induced liver injury, severe non-alcoholic fatty liver
             disease or other chronic liver diseases;

          4. Patients with baseline AFP level higher than 100ng/ml and possible malignant lesion on
             image, or AFP level higher than 100ng/ml for more than three months;

          5. Creatinine &gt; 1.5×ULN;

          6. Patients with other uncured malignant tumors;

          7. Patients with severe diseases of heart, lung, kidney, brain, blood system or other
             organs;

          8. Patients with any other reasons not suitable for the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong You, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Friendship Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hong You, Doctor</last_name>
    <phone>010-63139019</phone>
    <email>youhong30@sina.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jidong Jia, Doctor</last_name>
    <phone>010-63139816</phone>
    <email>jiamd@263.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Ditan Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100015</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wen Xie, Doctor</last_name>
      <phone>13651113763</phone>
      <email>Xiewen6218@163.com</email>
    </contact>
    <investigator>
      <last_name>Wen Xie, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoyuan Xu, Doctor</last_name>
      <phone>13001185762</phone>
      <email>yangpin@public3.bta.net.cn</email>
    </contact>
    <investigator>
      <last_name>Xiaoyuan Xu, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>302 Military Hospital Of China</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100039</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guofeng Chen, Doctor</last_name>
      <phone>13331119961</phone>
      <email>Bjchen302@yahoo.com.cn</email>
    </contact>
    <investigator>
      <last_name>Guofeng Chen, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>302 Military Hospital Of China</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100039</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanwei Li, Doctor</last_name>
      <phone>13601068628</phone>
      <email>lhw@medmail.com.cn</email>
    </contact>
    <investigator>
      <last_name>Hanwei Li, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Friendship Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoning Wu, Doctor</last_name>
      <phone>13439561979</phone>
      <email>wuxiaoningbs@126.com</email>
    </contact>
    <investigator>
      <last_name>Hong You, Postdoctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Youqing Xu, Doctor</last_name>
      <phone>13552212981</phone>
      <email>youqingxu@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Youqing Xu, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bo Feng, Doctor</last_name>
      <phone>13810254109</phone>
      <email>Xyfyfb_1@sina.com</email>
    </contact>
    <investigator>
      <last_name>Bo Feng, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing YouAn Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100069</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huiguo Ding, Doctor</last_name>
      <phone>13911683832</phone>
      <email>dinghuiguo@medmail.com.cn</email>
    </contact>
    <investigator>
      <last_name>Huiguo Ding, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoqing Liu, Doctor</last_name>
      <phone>13911761571</phone>
      <email>liuxqpumch@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Xiaoqing Liu, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PeKing University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100871</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xue'en Liu, Doctor</last_name>
      <phone>010-82802413</phone>
      <email>xueenliu@bjmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Xue'en Liu, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NanfangHospital,Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510515</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yongpeng Chen, Doctor</last_name>
      <phone>13924203581</phone>
      <email>Cypmu@yahoo.com.cn</email>
    </contact>
    <investigator>
      <last_name>Yongpeng Chen, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shijiazhuang Fifth Hospital</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>50021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huanwei Zheng, Doctor</last_name>
      <phone>13323119317</phone>
      <email>13323119317@189.cn</email>
    </contact>
    <investigator>
      <last_name>Huanwei Zheng, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital, Tongji Medical College ,Huazhong University of Science ＆Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>300030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tao Chen, Doctor</last_name>
      <phone>18971419301</phone>
      <email>corer0307@sina.com</email>
    </contact>
    <investigator>
      <last_name>Tao Chen, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sir Run Run Shaw Hospital,School of Medicine,Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Jiangsu</state>
        <zip>310016</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jihong Sun, Doctor</last_name>
      <phone>13957176538</phone>
      <email>braversun@sina.com</email>
    </contact>
    <investigator>
      <last_name>Xiaoming Yang, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Yanbian University</name>
      <address>
        <city>Yanbian</city>
        <state>Jilin</state>
        <zip>133000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongxin Piao, Doctor</last_name>
      <phone>15526770394</phone>
      <email>15526770394@163.com</email>
    </contact>
    <investigator>
      <last_name>Hongxin Piao, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>RenjiHospital,Shanghai Jiao Tong University,School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yimin Mao, Doctor</last_name>
      <phone>13003175438</phone>
      <email>Mym11968@yahoo.com.cn</email>
    </contact>
    <investigator>
      <last_name>Yimin Mao, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Huashan Hospital FuDan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guangfeng Shi, Doctor</last_name>
      <phone>13817780666</phone>
      <email>Gfshi2005@163.com</email>
    </contact>
    <investigator>
      <last_name>Guangfeng Shi, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongshan Hospital Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiyao Wang, Doctor</last_name>
      <phone>13616014132</phone>
      <email>Wang.jiyao@zs-hospital.sh.cn</email>
    </contact>
    <investigator>
      <last_name>Jiyao Wang, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai First People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lungen Lu, Doctor</last_name>
      <phone>13381616206</phone>
      <email>Lungenlu1965@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Lungen Lu, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Public Health Clinical Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>201508</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jilin Cheng, Doctor</last_name>
      <phone>18916035612</phone>
      <email>jilincheng@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jilin Cheng, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Shanxi Medical University</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <zip>30001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lijuan Huo, Doctor</last_name>
      <phone>13835107953</phone>
      <email>mymail5296@163.com</email>
    </contact>
    <investigator>
      <last_name>Lijuan Huo, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Hospital Affiliated to Logistics University of Chinese People's Armed Police Force</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300162</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hai Li, Doctor</last_name>
      <phone>15202265600</phone>
      <email>15202265600@163.com</email>
    </contact>
    <investigator>
      <last_name>Hai Li, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2013</study_first_submitted>
  <study_first_submitted_qc>September 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2013</study_first_posted>
  <last_update_submitted>January 12, 2016</last_update_submitted>
  <last_update_submitted_qc>January 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Friendship Hospital</investigator_affiliation>
    <investigator_full_name>Hong You</investigator_full_name>
    <investigator_title>Vice-Director Liver Research Centre</investigator_title>
  </responsible_party>
  <keyword>Liver Cirrhosis</keyword>
  <keyword>Hepatitis B</keyword>
  <keyword>Compensation</keyword>
  <keyword>Efficacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Entecavir</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

